Government Trades

Novonesis (Novozymes) B (NVZMY) Government Trades - Latest Congressional Stock Transactions

Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.

top performing (NVZMY) trades

Josh Gottheimer headshot
Josh Gottheimer
House (D-NJ)
49.90%

Recent Novonesis (Novozymes) B (NVZMY) Trades by Congress Members

See the most up-to-date Novonesis (Novozymes) B trades disclosed by US lawmakers, including purchase and sale amounts, transaction dates, and reporting details. View the most recent Novonesis (Novozymes) B trades made by congress members.

Josh GottheimerHouse (D-NJ)
$1K - $15KstockPurchaseNov 11, 2023Oct 16, 2023
House
Josh GottheimerHouse (D-NJ)
$1K - $15KstockSaleOct 15, 2023Sep 15, 2023
House